6. References

This contains references to sources and materials referenced in this report.

  1. Australia CW. Tests, treatments, and procedures for healthcare providers and consumers to question. 2017.
    http://www.choosingwisely.org.au/recommendations?displayby=MedicalTest (accessed.
  2. Canada CW. The Lists. 2017. http://www.choosingwiselycanada.org/wp-content/uploads/2014/01/Choosing-Wisely-Canada-collection-of-lists.pdf (accessed 14th June).
  3. USA CW. The Choosing Wisely Lists. 2017. http://www.choosingwisely.org/doctor-patient-lists/ (accessed 14th June).
  4. Excellence NIfHaC. Do not do recommendations. 2017. https://www.nice.org.uk/savingsandproductivity/collection (accessed 14th June).
  5. Elshaug AG, Watt AM, Mundy L, et al. Over 150 potentially low-value health care practices: an Australian study. Med J Aust 2012;197:556-60. https://www.ncbi.nlm.nih.gov/pubmed/23163685.
  6. Care ACoSaQiH. The Australian Atlas of Healthcare Variation. 2017. https://www.safetyandquality.gov.au/atlas/ (accessed 14th June).
  7. Department of Health. MBS data – Q210381-02. 2016. (accessed 26.10.2016).
  8. Department of Health. MBS Data. 2016. Report No. (accessed 26.10.2016).
  9. Medicare Australia Statistics. Standard MBS data. 2016. (accessed 26.10.2016).
  10. Australian Bureau of Statistics. Australian Demographic Statistics. 2015. http://www.abs.gov.au/ausstats/abs@.nsf/Previousproducts/3101.0Main%20Features1Jun%202015?opendocument&tabname=Summary&prodno=3101.0&issue=Jun%202015&num=&view=. (accessed 25 October).
  11. Department of Health. MBS data –Q203551. 2016. (accessed 26.10.2016).
  12. Department of Health. MBS Data – Q20354-02. 2016. (accessed 26.10.2016).
  13. Craig ME, Twigg SM, Donaghue KC, et al. National evidence-based clinical care guidelines for type 1 diabetes in children, adolescents and adults. Canberra: National Health and Medical Research Council, 2011. (accessed.
  14. Department of Health. PBS data. 2016.
  15. Department of Health. MBS data - Q20382-01. 2016.
  16. Gereben B, Zavacki AM, Ribich S, et al. Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling. Endocrine Reviews 2008;29:898-938. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647704/.
  17. Colagiuri S. Time to move to a glycated haemoglobin-based algorithm for diabetes screening and diagnosis? Med J Aust 2015;203:7-9. http://www.ncbi.nlm.nih.gov/pubmed/26126553.
  18. d'Emden MC, Shaw JE, Colman PG, et al. The role of HbA1c in the diagnosis of diabetes mellitus in Australia. Med J Aust 2012;197:220-1. http://www.ncbi.nlm.nih.gov/pubmed/22900870.
  19. d'Emden MC, Shaw JE, Jones GR, et al. Guidance concerning the use of glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus. Med J Aust 2015;203:89-90. http://www.ncbi.nlm.nih.gov/pubmed/26175248.
  20. Nankervis A, McIntyre HD, Moses R, et al. ADIP Consensus Guidelines for the Testing and Diagnosis of Hyperglycaema in Pregnancy in Australia and New Zealand. Australasian Diabetes in Pregnancy Society 2014:1–8.
  21. Nankervis A, Conn J. Gestational diabetes mellitus Negotiating the confusion. Australian Family Physician 2013;42:528-31. http://www.racgp.org.au/afp/2013/august/gestational-diabetes-mellitus/.
  22. Royal Australian College of General Practitioners. General practice management of type 2 diabetes. 2014.
  23. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. 2011. Report No. http://www.who.int/diabetes/publications/report-hba1c_2011.pdf (accessed 26.10.2016).
  24. American Diabetes Association. 12. Management of Diabetes in Pregnancy. Diabetes Care 2016;39:S94-S8. http://care.diabetesjournals.org/content/diacare/39/Supplement_1/S94.full.pdf.
  25. Gunton JE, Cheung NW, Davis TM, et al. A new blood glucose management algorithm for type 2 diabetes: a position statement of the Australian Diabetes Society. Med J Aust 2014;201:650-3. http://www.ncbi.nlm.nih.gov/pubmed/25495309.
  26. 9. Microvascular Complications and Foot Care. Diabetes Care 2015;38:S58-S66. http://care.diabetesjournals.org/content/diacare/38/Supplement_1/S58.full.pdf.
  27. Cameron AJ, Magliano DJ, Zimmet PZ, et al. The Metabolic Syndrome in Australia: Prevalence using four definitions. Diabetes Research and Clinical Practice 2007;77:471-8. http://www.sciencedirect.com/science/article/pii/S0168822707001076.
  28. Kidney Disease Improving Global Outcomes. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements 2013;3.
  29. Vasikaran SD, Paul Chubb SA. The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis. Endocrine 2016;52:222-5. http://dx.doi.org/10.1007/s12020-016-0900-2.
  30. Cavalier E, Bergmann P, Bruyere O, et al. The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club. Osteoporos Int 2016;27:2181-95. https://www.ncbi.nlm.nih.gov/pubmed/27026330.